• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mettler-Toledo International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    6/4/24 4:12:45 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email
    mtd-20240530
    0001037646false00010376462024-05-302024-05-30

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Form 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported):May 30, 2024
    Mettler Toledo International Inc
    (Exact name of registrant as specified in its charter)
    DelawareFile No.001-1359513-3668641
    (State or other jurisdiction
    of incorporation)
    (Commission File Number)(IRS Employer Identification No.)
    1900 Polaris Parkway
    Columbus
    OH
    and
    Im Langacher, P.O. Box MT-100
    CH Greifensee, Switzerland
    43240and 8606
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: 1-614-438-4511 and +41-44-944-22-11
    (Former name or former address, if changed since last report.)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, $0.01 par valueMTDNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ☐





    Item 1.01 Entry into a Material Definitive Agreement.

    On May 30, 2024, Mettler-Toledo International Inc. (the “Company”) and certain of its subsidiaries (together with the Company, the “Borrowers”), entered into Amendment No. 7 (the “Amendment”), which amended the credit agreement among the Company, certain of its subsidiaries and certain financial institutions, dated as of December 20, 2011 (as previously amended by that certain Amendment No. 1 to Credit Agreement dated as of November 26, 2013, that certain Amendment No. 2 to Credit Agreement dated as of April 24, 2015, that certain Amendment No. 3 to Credit Agreement dated as of December 17, 2015, that certain Amendment No. 4 to Credit Agreement dated as of June 15, 2018, that certain Amendment No. 5 to Credit Agreement dated as of June 25, 2021 and that certain Amendment No. 6 to Credit Agreement dated as of May 17, 2023, the “Credit Agreement” and as amended by the Amendment, the “Amended Credit Agreement”) by and among the Borrowers, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto. The Amended Credit Agreement is described in Item 2.03 hereof.

    Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The Amended Credit Agreement is a revolving credit facility. One existing subsidiary of the Company was removed as a Revolving Borrower and a Swingline Borrower under the Amended Credit Agreement.

    The material terms of the Amended Credit Agreement are substantially similar to the terms of the Credit Agreement, except with respect to maturity and maximum facility size. The principal amount committed under the Credit Agreement of $1,250,000,000 has been increased under the Amended Credit Agreement to $1,350,000,000.

    Amounts outstanding under the Amended Credit Agreement are repayable in 2029, which maturity can be extended for two additional years at the Company’s request made on or before April 30, 2028. Borrowings under the Amended Credit Agreement are not subject to any scheduled principal payments prior to maturity and bear interest at a rate equal to SOFR plus a 10 basis point credit spread adjustment plus a margin ranging from 0.875% to 1.15% depending on the Company’s consolidated net leverage ratio. The margin is currently set at 0.975% until the Administrative Agent’s receipt of the quarterly financial statements for the fiscal quarter ending on September 30, 2024, at which point it will revert to the margin defined in the pricing grid. The Company must also pay facility fees that are tied to its then-applicable consolidated net leverage ratio.

    The Amended Credit Agreement also includes certain modifications to the Credit Agreement relating to the replacement of the Canadian Dollar Offered Rate with the Canadian Overnight Repo Rate Average Rate as the interest rate benchmark for any loans denominated in Canadian Dollars and adjusts certain other provisions to reflect current documentation standards and other agreed modifications.

    The Amended Credit Agreement requires the Company to maintain (i) a ratio of net funded indebtedness to Consolidated EBITDA of 3.5 to 1.0 or less except that the required maximum ratio may increase to 4.0 to 1.0 for the four consecutive fiscal quarter period commencing with the fiscal quarter in which an acquisition having total consideration (including, without limitation, all cash payments, assumed indebtedness, issued equity interests and earn outs in connection with such acquisition) greater than $250,000,000 and (ii) an interest coverage ratio of 3.0 to 1.0 or greater. The Amended Credit Agreement also contains certain customary affirmative and negative covenants, which, among other things, limit the Company’s ability to grant liens or incur debt at a subsidiary level. Events of default under the Amended Credit Agreement include non-payment, covenant breaches, incorrect representations and warranties, cross-default, insolvency proceedings, inability to pay debts, attachment, judgments, ERISA events, and change of control.

    The Amended Credit Agreement is unsecured. The Company provides a guarantee under the Amended Credit Agreement of borrowings and other specified obligations of each subsidiary borrower.

    The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Amendment, a copy of which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated herein by reference.




    Item 9.01 Financial Statements and Exhibits
        (d) Exhibits
    Exhibit No.Description
    10.1
    Amendment No 7. to the Credit Agreement among Mettler-Toledo International Inc., certain of its subsidiaries, JPMorgan Chase Bank, N.A., and certain other financial institutions, dated as of December 20, 2011.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).*

    * Submitted electronically with this Report in accordance with the provisions of Regulation S-T.




    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
     METTLER-TOLEDO INTERNATIONAL INC.
       
    Date:  June 4, 2024By:/s/ Michelle M. Roe
       
      Michelle M. Roe
      General Counsel


    Get the next $MTD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    12/15/2025$1600.00Neutral → Buy
    BofA Securities
    12/9/2025$1475.00Neutral
    Goldman
    12/2/2025$1550.00Equal-Weight
    Morgan Stanley
    6/24/2025$1325.00Overweight
    Barclays
    5/20/2025$1350.00Neutral → Buy
    UBS
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    More analyst ratings

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mettler-Toledo upgraded by BofA Securities with a new price target

    BofA Securities upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,600.00

    12/15/25 9:08:50 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Goldman initiated coverage on Mettler-Toledo with a new price target

    Goldman initiated coverage of Mettler-Toledo with a rating of Neutral and set a new price target of $1,475.00

    12/9/25 8:51:34 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Morgan Stanley initiated coverage on Mettler-Toledo with a new price target

    Morgan Stanley initiated coverage of Mettler-Toledo with a rating of Equal-Weight and set a new price target of $1,550.00

    12/2/25 8:27:37 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    11/15/23 9:00:20 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Mettler-Toledo International Inc.

    SCHEDULE 13G - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/13/26 4:29:59 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-K filed by Mettler-Toledo International Inc.

    10-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    2/6/26 11:53:50 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    2/5/26 4:39:49 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions. Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Office

    2/5/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp

    1/20/26 4:30:00 PM ET
    $MTD
    $STE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    Mettler-Toledo International Inc. to Host Fourth Quarter 2025 Earnings Conference Call

    Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its fourth quarter 2025 financial results after the market close on Thursday, February 5, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader an

    1/9/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tokich Michael J was granted 50 shares (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    2/19/26 11:37:44 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Financial Officer Vadala Shawn exercised 800 shares at a strike of $595.31 and sold $1,128,096 worth of shares (800 units at $1,410.12) (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    2/11/26 2:08:09 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Tokich Michael J

    3 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    2/6/26 11:23:00 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Financials

    Live finance-specific insights

    View All

    Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions. Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Office

    2/5/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. to Host Fourth Quarter 2025 Earnings Conference Call

    Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its fourth quarter 2025 financial results after the market close on Thursday, February 5, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader an

    1/9/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. Reports Third Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced third quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 6% compared with the prior year. Net earnings per diluted share as reported (EPS) were $10.57, compared with $9.96 in the prior-year period. Adjusted EPS was $11.15, an increase of 9% over the prior-year amount of $10.21. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Third Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "Our third quarter results were strong a

    11/6/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    View All

    METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp

    1/20/26 4:30:00 PM ET
    $MTD
    $STE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Pablo Perversi to Join METTLER TOLEDO Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Perversi is the President of Europe at Danone, a leading global food and beverage company, and a member of its Executive Committee. Prior to his current role, Pablo served as Chief Innovation, Quality, and Sustainability Officer and President of Gourmet Division for Barry Callebaut from 2017 to 2022. Before that, he held various roles of increasing responsibility at Unilever from 1993 to 2017, his last position there being Vice President of Foods Europe. Roland Diggelmann, Chair of the Board, stated, "Pablo is a very accomplished

    8/4/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/13/24 5:09:38 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/10/23 1:38:29 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/10/22 5:03:51 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials